Top 5 Stocks to Buy Now: Expert Recommendations for Indian Investors
Get the latest stock recommendations from top market analysts and brokerages, covering opportunities in banking, energy, metals, and infrastructure sectors.
Get the latest stock recommendations from top market analysts and brokerages, covering opportunities in banking, energy, metals, and infrastructure sectors.
Motilal Oswal’s latest report highlights the Indian IT sector’s potential for growth, driven by AI adoption. HCLTech and Coforge are among the top picks. Learn more about the sector’s outlook and key players.
Get the latest updates on gold and silver prices in India, including rates in major cities like Delhi, Mumbai, and Bengaluru, and understand how US inflation data and global market trends are impacting the precious metals market.
Ola Electric shares bounce back after founder Bhavish Aggarwal sells stake, what does this mean for Indian investors and the company’s future plans?
Ahluwalia Contracts shares jumped over 7% after securing a major EPC order worth Rs 888 crore from the Bihar State Tourism Development Corporation. Get the latest updates on the Indian stock market and major corporate actions affecting investor sentiment.
Nephrocare Health Services Ltd. makes a strong debut on the National Stock Exchange, listing at a 6.52% premium over its issue price. Get the latest updates on the company’s IPO and its impact on the Indian stock market.
Park Medi World Ltd. shares listed at a discount on the National Stock Exchange. What does this mean for Indian investors and the healthcare sector?
Akzo Nobel India shares fell 15% after a large block deal. What does this mean for investors and what are the key takeaways from the company’s Q2 results?
The Indian rupee witnessed high volatility against the US dollar in early trade due to factors like easing crude oil prices, uncertainty over the India-US trade deal, and persistent foreign fund outflows.
Vishal Mega Mart shares are in focus after Motilal Oswal reiterated its ‘Buy’ rating with a revised target price of Rs 170, implying an upside of 25% from the current market price.